DermAb.io

DermAb.io is at the forefront of biotechnology research, pioneering innovative solutions for precision medicine in the treatment of chronic and autoimmune diseases. DermAb.io is dedicated to transforming healthcare by developing a cutting-edge clinical decision support system designed to personalize biologic therapies. Their non-invasive technology painlessly retrieves biomarkers from the skin’s surface, providing physicians with the predictive power to prescribe the most effective biological medication immediately. This approach significantly reduces the trial-and-error costs, which can average $12,000 per patient, and alleviates months of unnecessary suffering.

DermAb.io is committed to improving patient outcomes and reducing healthcare costs through its advanced platform. With a focus on addressing the unique needs of women affected by autoimmune diseases, DermAb.io launched the @FEMMUNE initiative in 2024 to raise awareness about sex and gender disparities in autoimmune disease treatment. The primary address of DermAb.io is Nativ Haor, 1, Haifa, IL. DermAb.io is poised to revolutionize personalized medicine and improve the quality of life for countless individuals.

We invite the manager of DermAb.io to take the next step and create a customized and exclusive company showcase and product listing on our platform, further enhancing their commercial development and market presence.